Group 1 - The Hong Kong Innovative Drug ETF (159567) experienced a decline of 2.05% on December 9, with a trading volume of 1.237 billion yuan [1] - The fund's shares increased by 207 million, bringing the total shares to 10.361 billion, with a total increase of 686 million shares over the past 20 trading days [1] - The latest net asset value of the fund is calculated to be 8.47 billion yuan [1] Group 2 - The performance benchmark for the Hong Kong Innovative Drug ETF is the National Securities Hong Kong Stock Connect Innovative Drug Index return rate (adjusted for valuation exchange rate) [1] - The fund is managed by Yinhua Fund Management Co., Ltd., with the fund manager being Ma Jun [1] - Since its establishment on January 3, 2024, the fund has achieved a return of 63.50%, with a return of 0.09% over the past month [1]
12月9日港股创新药ETF（159567）份额增加2.07亿份
Xin Lang Cai Jing·2025-12-10 01:04